DE69106516T2 - Pyridopyrazinderivate zur behandlung von drogenmissbrauch und -sucht. - Google Patents

Pyridopyrazinderivate zur behandlung von drogenmissbrauch und -sucht.

Info

Publication number
DE69106516T2
DE69106516T2 DE69106516T DE69106516T DE69106516T2 DE 69106516 T2 DE69106516 T2 DE 69106516T2 DE 69106516 T DE69106516 T DE 69106516T DE 69106516 T DE69106516 T DE 69106516T DE 69106516 T2 DE69106516 T2 DE 69106516T2
Authority
DE
Germany
Prior art keywords
addiction
drug abuse
treating drug
pyridopyrazine derivatives
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69106516T
Other languages
English (en)
Other versions
DE69106516D1 (de
Inventor
Gene BRIGHT
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of DE69106516D1 publication Critical patent/DE69106516D1/de
Application granted granted Critical
Publication of DE69106516T2 publication Critical patent/DE69106516T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DE69106516T 1990-06-29 1991-05-28 Pyridopyrazinderivate zur behandlung von drogenmissbrauch und -sucht. Expired - Fee Related DE69106516T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/US1990/003708 WO1992000075A1 (en) 1990-06-29 1990-06-29 Pyridopyrazine derivatives for treating substance abuse and addiction
PCT/US1991/003749 WO1992000074A2 (en) 1990-06-29 1991-05-28 Pyridopyrazine derivatives for treating substance abuse and addiction

Publications (2)

Publication Number Publication Date
DE69106516D1 DE69106516D1 (de) 1995-02-16
DE69106516T2 true DE69106516T2 (de) 1995-05-11

Family

ID=22220931

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69106516T Expired - Fee Related DE69106516T2 (de) 1990-06-29 1991-05-28 Pyridopyrazinderivate zur behandlung von drogenmissbrauch und -sucht.

Country Status (17)

Country Link
US (1) US5616585A (de)
EP (1) EP0536173B1 (de)
JP (1) JPH05507274A (de)
KR (1) KR930701171A (de)
AT (1) ATE116545T1 (de)
AU (1) AU651977B2 (de)
CA (1) CA2086335C (de)
DE (1) DE69106516T2 (de)
DK (1) DK0536173T3 (de)
ES (1) ES2066447T3 (de)
HU (1) HUT62797A (de)
IE (1) IE64467B1 (de)
IL (1) IL98588A (de)
MY (1) MY106553A (de)
NZ (1) NZ238750A (de)
WO (2) WO1992000075A1 (de)
ZA (1) ZA915012B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6231833B1 (en) 1999-08-05 2001-05-15 Pfizer Inc 2,7-substituted octahydro-1H-pyrido[1,2-A]pyrazine derivatives as ligands for serotonin receptors
HN1999000146A (es) * 1998-09-21 2000-11-11 Pfizer Prod Inc Agentes farmaceuticos para el tratamiento de la enfermedad de parkinson, adhd y microadenomas.
EP1177792A3 (de) * 2000-07-27 2002-10-23 Pfizer Products Inc. Dopamin-d4-ligande zur behandlung von gaudi-suchenden krankheiten
UA110688C2 (uk) 2012-09-21 2016-01-25 Пфайзер Інк. Біциклічні піридинони
EA033423B1 (ru) 2015-02-03 2019-10-31 Pfizer Циклопропанбензофуранилпиридопиразиндионы

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK144213C (da) * 1979-06-20 1982-06-21 H B Nielsen Hylster til garnspole
US4777173A (en) * 1987-03-25 1988-10-11 Bristol-Myers Company Method for treatment of alcohol abuse
DE3727879A1 (de) * 1987-08-21 1989-03-02 Troponwerke Gmbh & Co Kg Verwendung von 2-pyrimidinyl-1-piperazin-derivaten
DE3736974A1 (de) * 1987-10-31 1989-05-11 Troponwerke Gmbh & Co Kg Verwendung von 2-pyrimidinyl-1-piperazin-derivaten
IL91451A0 (en) * 1988-08-30 1990-04-29 Bristol Myers Co Pharmaceutical compositions comprising azapiron compounds and their use in the treatment of addiction
MX19222A (es) * 1989-01-23 1993-12-01 Pfizer Agentes ansioliticos bis-aza-biciclicos

Also Published As

Publication number Publication date
MY106553A (en) 1995-06-30
IL98588A0 (en) 1992-07-15
IE64467B1 (en) 1995-08-09
US5616585A (en) 1997-04-01
WO1992000075A1 (en) 1992-01-09
EP0536173B1 (de) 1995-01-04
AU7909491A (en) 1992-01-23
CA2086335C (en) 1996-01-02
NZ238750A (en) 1999-09-29
JPH05507274A (ja) 1993-10-21
AU651977B2 (en) 1994-08-11
DE69106516D1 (de) 1995-02-16
IE912259A1 (en) 1992-01-01
DK0536173T3 (da) 1995-05-01
ATE116545T1 (de) 1995-01-15
IL98588A (en) 1995-06-29
ZA915012B (en) 1993-02-24
WO1992000074A3 (en) 1992-03-05
HU9204138D0 (en) 1993-04-28
ES2066447T3 (es) 1995-03-01
KR930701171A (ko) 1993-06-11
HUT62797A (en) 1993-06-28
WO1992000074A2 (en) 1992-01-09
CA2086335A1 (en) 1991-12-30
EP0536173A1 (de) 1993-04-14

Similar Documents

Publication Publication Date Title
MY104861A (en) Bis-aza-bicyclic anxiolytic agents.
FI813288L (fi) Derivat av imidazo/1,2-a/pyridin deras framstaellning och anvaendning vid behandling av sjukdomar
YU73991A (sh) POSTUPAK ZA DOBIJANJE 2-METIL-10-(4-METIL-1-PIPERAZINIL)-4H- TIENO 2,3-b 1,5 BENZODIAZEPINA
ATE182593T1 (de) Chemische verbindungen mit pde-iv inhibitierende wirkung
DK0839040T3 (da) Anvendelse af cGMP-phoshodiesterase til behandling af impotens
AR025960A1 (es) Biblioteca de sustancias que contiene imidazo-5-il-aminas biciclicas y/o imidazo 3-il-aminas biciclicas, procedimiento para la preparacion de estabiblioteca de sustancias, y uso de sustancias de esta biblioteca para la preparacion de medicamentos para el tratamiento del dolor
KR880001641A (ko) 니트로푸란 유도체, 그의 제법 및 치료에의 응용
ATE242246T1 (de) (1,2,3)-triazolo(4,5-d)pyrimidin-derivate als antithrombotische mittel
BG98124A (en) Active pyrrole-(2,3-)pyridine derivatives
DE59305236D1 (de) Kombinationspräparat aus Flupirtin und Morphin zur Behandlung von Schmerzen und zur Vermeidung der Morphin-Abhängigkeit
ATE104852T1 (de) Verwendung von bicyclischen imidazol-verbindungen zur behandlung von hyperaldosteronismus.
DE69106516T2 (de) Pyridopyrazinderivate zur behandlung von drogenmissbrauch und -sucht.
DK1109814T3 (da) 5-Heterocyclylpyrazolo[4,3-d]pyrimidin-7-oner til behandling af mandlig erektil dysfunktion
ATE151291T1 (de) Penciclovir und famciclovir und verwandte guaninderivate zur behandlung von hiv-1- infektionen
DE3768978D1 (de) Pyrrolo(1,2-a)(4,1)benzoxazepine, verfahren zur ihrer herstellung, pharmazeutische praeparate enthaltend diese verbindungen, sowie therapeutische verwendung.
FR2722789B1 (fr) Derives d'acide imidazo (1,2-a)indeno(1,2-e) pyrazine-2-carboxylique, leur preparation et les medicaments les contenant
DE59107405D1 (de) Ein Imidazobenzodiazepin zur Behandlung von Schlafstörungen
DE69217616D1 (de) Verfahren zur Herstellung von (S)-1-Phenyl-1,3-Propanediol und Derivaten
DE69026936D1 (de) 5-aminocarbonyl-5h-dibenzo-a,d]cyclohepten-5,10-imine zur behandlung von epilepsie und kokainsucht
ES2062351T3 (es) Derivados de triazolo (4,5-c) piridina anticonvulsivos.
DE3882875T2 (de) Verwendung von Pyrrol[3,2,1-hi]indol-Derivaten zur Herstellung eines Arzneimittels zur Behandlung von Diabetes.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee